Latest Breaking News On - Lifesci advisors - Page 1 : comparemela.com

Opthea Announces Placement and Partially Underwritten

Opthea Announces Placement and Partially Underwritten
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandFrederic guerardFred guerardVegfd researchOpthea limitedBell potter securitiesInvestment in biotechnology companiesLifesci advisorsCompany american depositary shares nasdaqExchange commissionFinancial services pty ltdAccelerated non renounceable entitlement offerEntitlement offerAflibercept studyBiologics license application

ProKidney Announces Pricing of its Upsized $130 Million

ProKidney Announces Pricing of its Upsized $130 Million
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesWinston salemNorth carolinaBruce culletonEthan holdawayBroadridge financial solutionsExchange commissionCompany at prokidney corpEquity syndicate prospectus departmentEquity syndicate departmentJp morgan securitiesLifesci advisorsGuggenheim securitiesProkidney corpIsland avenue

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

WINSTON-SALEM, N.C., June 11, 2024 ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an.

North carolinaUnited statesNew yorkWinston salemBruce culletonEthan holdawayJp morgan securitiesBroadridge financial solutionsGuggenheim securitiesGlobenewswire incLifesci advisorsEquity syndicate departmentExchange commissionProkidney corpEquity syndicate prospectus departmentSyndicate prospectus department

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Winston salemNorth carolinaUnited statesNew yorkBruce culletonEthan holdawayEquity syndicate prospectus departmentLifesci advisorsBroadridge financial solutionsCompany at prokidney corpGuggenheim securitiesExchange commissionProkidney corpEquity syndicate departmentJp morgan securitiesIsland avenue

Cellectis S A : Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications 12 Jun 2024 22:30 CEST .

France generalNorth carolinaUnited statesNew yorkAshleyr robinsonPascalyne wilsonCellecti pulseagilePatricia sosa navarroArthur strilJulien valtonCellectis the company euronext growthSecurities exchange commissionNature communicationsEuronext growthVice president gene therapyAdult hemoglobin